TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up February 22, 2013
TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014